Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus with Carboplatin, Paclitaxel, and Bevacizumab in Metastatic Melanoma
NCT00976573Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in melanoma, sponsored by Cancer and Leukemia Group B. Started Apr 2010; status: completed.
02
Drugs
everolimus
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00976573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00976573.